HK

Harsh Kumar

Active Director Director DIN 10391956
DIN 10391956 First appointment Nov 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Harsh Kumar

Data last updated:

Harsh Kumar is a Director at Dhanwantri Lions Eye Care Pollycilines Private Limited (since 2023). The company operates in Healthcare. Dhanwantri Lions Eye Care Pollycilines Private Limited reported revenue of ₹42,031 (FY 2024).

DIN 10391956
Primary Designation Director
Industry Healthcare
First Appointment 15 Nov 2023
Oldest Company Age 2 yrs
Largest company Dhanwantri Lions Eye Care Pollycilines Private Limited · ₹42,031 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Nov 20232023₹42,031 (FY 2024)Active

Board colleagues of Harsh Kumar

Directorship timeline

Open interactive timeline →
Dhanwantri Lions Eye Care Pollycilines Private Limited
Premium access

Shareholding and investment profile for Harsh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harsh Kumar

Harsh Kumar currently holds 1 directorship: Dhanwantri Lions Eye Care Pollycilines Private Limited (Director, since 15 Nov 2023, revenue ₹42,031 (FY 2024)).

Harsh Kumar was first appointed on 15 Nov 2023 as Director at Dhanwantri Lions Eye Care Pollycilines Private Limited.

The current boards of Harsh Kumar's companies include Dilip Kumar Mathuri (Dhanwantri Lions Eye Care Pollycilines Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available